Skip to main content
Fig. 1 | BMC Bioinformatics

Fig. 1

From: Multiple roles of apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) in human tumors: a pan-cancer analysis

Fig. 1

Expression level of the APOBEC3B gene in different tumors and pathological stages. a The mRNA expression of the APOBEC3B in different tumor subtypes and adjacent normal tissues. **P < 0.01; ***P < 0.001. b The mRNA expression of the APOBEC3B in ACC, LAML, LGG, OV, SKCM, TGCT, THYM, and UCS tumor types in the TCGA dataset, corresponding normal tissues of the GTEx database were included as controls. ***P < 0.001. c The protein levels of APOBEC3B between normal tissues and primary tissues of breast cancers, clear cell RCC, hepatocellular carcinomas, PAAD, UCEC, HNSC, and LUAD, based on the CPTAC dataset. **P < 0.01. d The relationship between APOBEC3B expression and clinical stages in ACC, BLCA, CHOL, KIRC, KIRP, LIHC, OV, and THCA tumor types

Back to article page